| Hillary Malone Harris, | |
|
4801 University Sq, Suite 19, Huntsville, AL 35816-1825 | |
| (256) 837-2470 | |
| (256) 837-2471 |
| Full Name | Hillary Malone Harris |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 4801 University Sq, Huntsville, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083942478 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2842 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Hillary Malone Harris, 4801 University Sq, Suite 19, Huntsville, AL 35816-1825 Ph: (256) 837-2470 | Hillary Malone Harris, 4801 University Sq, Suite 19, Huntsville, AL 35816-1825 Ph: (256) 837-2470 |
News Archive
A new study from Lawson Health Research Institute, Western University and University of Alberta suggests that COVID-19 affects the human body's blood concentration levels of specific metabolites - small molecules broken down in the human body through the process of metabolism.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that data from its Hsp90 chaperone and Hedgehog pathway inhibitor programs will be presented during the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Ill. from June 4 through June 8, 2010.
In this post in the Results for Development Institute's "Center for Global Health R&D Policy Assessment" blog, Project Director Jean Arkedis and Program Associate Edith Han interview Megumi Gordon, deputy director for malaria at the Clinton Health Access Initiative (CHAI), "to take an exclusive look into the Affordable Medicines Facility for Malaria (AMFm) and its innovative mechanism to increase access to antimalarials."
Directly observed therapy (DOT) for multidrug-resistant tuberculosis (MDR TB) was associated with a 77 percent decrease in mortality in the United States, compared to self-administered therapy from 1993 to 2013, according to new research presented at the ATS 2017 International Conference.
› Verified 6 days ago
Jennifer Paige Saliba, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 185 Chateau Dr Sw Ste 102, Huntsville, AL 35801 Phone: 615-828-6885 | |
Mrs. Rebecca A. Hughes, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4801 University Sq, Suite 19, Huntsville, AL 35816 Phone: 256-837-2470 Fax: 256-837-2471 | |
Mrs. Jennifer B. Mckinney, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Sivley Rd Sw, Huntsville, AL 35801 Phone: 256-265-7952 | |
Mrs. Robin Grace Maise, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2075 Max Luther Dr Nw, Huntsville, AL 35810 Phone: 256-852-5600 Fax: 256-852-6722 | |
Jennie Sue Cantrell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 42 Saint Charles Sq, Huntsville, AL 35801 Phone: 256-541-5666 | |
Mrs. Jenna Marie Dees, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3000 Johnson Rd Sw, Huntsville, AL 35805 Phone: 256-650-1701 Fax: 256-650-1781 | |
Mrs. Jenny Stone Gibson, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2011 Gallatin St Sw, Huntsville, AL 35801 Phone: 256-509-4398 |